1-4 of 4
Valérie Lallemand-Breitenbach
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic

Nabih Maslah1, PharmD, Tracy Dagher, PhDstudent, Valérie Edmond, PhD, Bruno Cassinat, PharmD, PhD, Valérie Lallemand-Breitenbach, PhD, Emmanuelle Verger, PhD, Isabelle Plo, PhD, Jean-Jacques Kiladjian, MD PhD, Jean-Luc Villeval, PhD, Hugues de Thé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 52.
https://doi.org/10.1182/blood-2018-99-112518
Published: 2018
Journal Articles

ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation

Zeina Dassouki, Umut Sahin, Hiba El Hajj, Florence Jollivet, Youmna Kfoury, Valérie Lallemand-Breitenbach, Olivier Hermine, Hugues de Thé, Ali Bazarbachi
Journal: Blood
Blood (2015) 125 (3): 474–482.
https://doi.org/10.1182/blood-2014-04-572750
Published: 2015
Includes: Supplemental data
Journal Articles

Retinoic acid plus arsenic trioxide, the ultimate panacea for acute promyelocytic leukemia?

Valérie Lallemand-Breitenbach, Hugues de Thé
Journal: Blood
Blood (2013) 122 (12): 2008–2010.
https://doi.org/10.1182/blood-2013-06-505115
Published: 2013
Journal Articles

A new oncoprotein catabolism pathway

Valérie Lallemand-Breitenbach, Hugues de Thé
Journal: Blood
Blood (2010) 116 (13): 2200–2201.
https://doi.org/10.1182/blood-2010-07-294025
Published: 2010